Editorial: New lights Through Old Windows: Metformin and Derivatives as Anti-Cancer Treatments

Detalles Bibliográficos
Autores principales: Moldasheva, Aiman, Surov, Vladimir, Aljofan, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086272/
https://www.ncbi.nlm.nih.gov/pubmed/35559266
http://dx.doi.org/10.3389/fphar.2022.889642
_version_ 1784703960210210816
author Moldasheva, Aiman
Surov, Vladimir
Aljofan, Mohamad
author_facet Moldasheva, Aiman
Surov, Vladimir
Aljofan, Mohamad
author_sort Moldasheva, Aiman
collection PubMed
description
format Online
Article
Text
id pubmed-9086272
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90862722022-05-11 Editorial: New lights Through Old Windows: Metformin and Derivatives as Anti-Cancer Treatments Moldasheva, Aiman Surov, Vladimir Aljofan, Mohamad Front Pharmacol Pharmacology Frontiers Media S.A. 2022-04-26 /pmc/articles/PMC9086272/ /pubmed/35559266 http://dx.doi.org/10.3389/fphar.2022.889642 Text en Copyright © 2022 Moldasheva, Surov and Aljofan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Moldasheva, Aiman
Surov, Vladimir
Aljofan, Mohamad
Editorial: New lights Through Old Windows: Metformin and Derivatives as Anti-Cancer Treatments
title Editorial: New lights Through Old Windows: Metformin and Derivatives as Anti-Cancer Treatments
title_full Editorial: New lights Through Old Windows: Metformin and Derivatives as Anti-Cancer Treatments
title_fullStr Editorial: New lights Through Old Windows: Metformin and Derivatives as Anti-Cancer Treatments
title_full_unstemmed Editorial: New lights Through Old Windows: Metformin and Derivatives as Anti-Cancer Treatments
title_short Editorial: New lights Through Old Windows: Metformin and Derivatives as Anti-Cancer Treatments
title_sort editorial: new lights through old windows: metformin and derivatives as anti-cancer treatments
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086272/
https://www.ncbi.nlm.nih.gov/pubmed/35559266
http://dx.doi.org/10.3389/fphar.2022.889642
work_keys_str_mv AT moldashevaaiman editorialnewlightsthrougholdwindowsmetforminandderivativesasanticancertreatments
AT surovvladimir editorialnewlightsthrougholdwindowsmetforminandderivativesasanticancertreatments
AT aljofanmohamad editorialnewlightsthrougholdwindowsmetforminandderivativesasanticancertreatments

Ejemplares similares